PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10847306::ACT004094

MR-22

Evidence text

Paper-level observation

Section 3.5: MR-22 displayed low hemolytic activities against human erythrocytes (Figure 2F).
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Hemolytic
Measure
hemolysis
Comparator
=
Raw observation
low hemolytic activities
Normalized measurement
=3.5%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
MAKRRKKAKKKAKKAKKRRRRRNH
Standardization
ready simple

Source publication

The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli.

Frontiers in Cellular and Infection Microbiology · 2024

DOI 10.3389/fcimb.2024.1334378 PMC10847306
Parent mention

Related peptide identities

PEPDIA-PLP-001966

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.